To the best of our knowledge there are To the best of our knowledge there are no measures of 'psychodynamic origin' speno measures of 'psychodynamic origin' specifically related to avoidant personality cifically related to avoidant personality disorder and hence we used the PDBQ. disorder and hence we used the PDBQ. Furthermore, it was not feasible to keep Furthermore, it was not feasible to keep the independent assessors who completed the independent assessors who completed the SCID-II unaware of the treatment the SCID-II unaware of the treatment group in a number of instances. group in a number of instances.
Post-treatment CBT was significantly Post-treatment CBT was significantly superior to BDT on all 'primary' outcome superior to BDT on all 'primary' outcome measures. A significance level of measures. A significance level of a a¼0.1 set 0.1 set rather than 0.01 as claimed by Leichsenring rather than 0.01 as claimed by Leichsenring & Leibing. Even if we exclude the SPAI & Leibing. Even if we exclude the SPAI scores ( scores (P P¼0.09), this still leaves superior 0.09), this still leaves superior outcome for CBT on three out of four outoutcome for CBT on three out of four outcome variables. The lack of power to detect come variables. The lack of power to detect differences between the waiting-list control differences between the waiting-list control group and the active treatments is acknowlgroup and the active treatments is acknowledged as a limitation. edged as a limitation.
There are important differences beThere are important differences between our study and that of Svartberg tween our study and that of Svartberg et et al al (2004) . Svartberg (2004) . Svartberg et al et al included all types included all types of cluster C and self-defeating personality of cluster C and self-defeating personality disorders, rather than limiting their study disorders, rather than limiting their study to avoidant personality disorder. Twoto avoidant personality disorder. Twofifths of their sample did not fulfil criteria fifths of their sample did not fulfil criteria for avoidant personality disorder treatment for avoidant personality disorder treatment and treatment consisted of 40 rather than and treatment consisted of 40 rather than of 20 sessions. Furthermore, outcome with of 20 sessions. Furthermore, outcome with respect to personality disorders (sic) was respect to personality disorders (sic) was only assessed with the Millon Clinical only assessed with the Millon Clinical Multiaxial Inventory (Millon, 1994) , rather Multiaxial Inventory (Millon, 1994) , rather than with the gold standard SCID-II. Finalthan with the gold standard SCID-II. Finally, the lack of a control group in the study ly, the lack of a control group in the study of Svartberg of Svartberg et al et al renders the results diffirenders the results difficult to interpret. cult to interpret.
In contrast to most other psychotherapy In contrast to most other psychotherapy studies, we did our utmost to prevent an efstudies, we did our utmost to prevent an effect of investigator allegiance. The study fect of investigator allegiance. The study was designed in close cooperation with was designed in close cooperation with two psychodynamic therapists (G.F. and two psychodynamic therapists (G.F. and H.K.) and two cognitive-behavioural thera-H.K.) and two cognitive-behavioural therapists (A.B. and A.K.), who all fully participists (A.B. and A.K.), who all fully participated in the design of the study, selection of pated in the design of the study, selection of measures, treatment manuals (including demeasures, treatment manuals (including degree of flexibility) and therapists. gree of flexibility) and therapists. (1995) documented increased vascular morbidity at 2-year folcreased vascular morbidity at 2-year follow-up in patients with anti-phospholipid low-up in patients with anti-phospholipid antibodies who were newly admitted for antibodies who were newly admitted for psychiatric treatment. These patients psychiatric treatment. These patients showed a range of cardiovascular accidents showed a range of cardiovascular accidents (arterial or venous thrombosis, pulmonary (arterial or venous thrombosis, pulmonary embolism and myocardial infarction). The embolism and myocardial infarction). The negative control group without anti-phosnegative control group without anti-phospholipid antibodies had no vascular compholipid antibodies had no vascular complications during follow-up. plications during follow-up.
Vascular events associated with such Vascular events associated with such autoantibodies range from superficial to autoantibodies range from superficial to life-threatening multiple organ thrombosis life-threatening multiple organ thrombosis developing over a short period ('catadeveloping over a short period ('catastrophic' anti-phospholipid syndrome). strophic' anti-phospholipid syndrome). Thrombosis in anti-phospholipid syndrome Thrombosis in anti-phospholipid syndrome appears to be a 'two-hit' phenomenon. appears to be a 'two-hit' phenomenon. Autoantibodies (the first 'hit') are continuAutoantibodies (the first 'hit') are continually present in the circulation, yet a local ally present in the circulation, yet a local trigger (the second 'hit') is required to intrigger (the second 'hit') is required to induce thrombus formation. Erkan & Lockduce thrombus formation. Erkan & Lockshin (2006) recently suggested the shin (2006) recently suggested the elimination of reversible thrombosis risk elimination of reversible thrombosis risk factors and heparin prophylaxis during factors and heparin prophylaxis during high-risk periods in people with persistent high-risk periods in people with persistent anti-phospholipid antibodies. Chengappa anti-phospholipid antibodies. Chengappa et al et al (1991) and Schwartz (1991) and Schwartz et al et al (1998 Schwartz et al et al ( ) de-(1998 demonstrated a high prevalence of anti-phosmonstrated a high prevalence of anti-phospholipid antibodies (about 30%) in pholipid antibodies (about 30%) in patients. A prospective study is ongoing in patients. A prospective study is ongoing in our departments to confirm the prevalence our departments to confirm the prevalence of anti-phospholipid antibodies with a first of anti-phospholipid antibodies with a first episode of acute psychosis before and after episode of acute psychosis before and after neuroleptic treatment. If historical data are neuroleptic treatment. If historical data are confirmed, more attention should be paid confirmed, more attention should be paid to the fact that up to one-third of patients to the fact that up to one-third of patients presenting with psychosis have anti-phospresenting with psychosis have anti-phospholipid antibodies and are at risk of cardipholipid antibodies and are at risk of cardiovascular or respiratory morbidity/ ovascular or respiratory morbidity/ mortality when neuroleptic treatment or mortality when neuroleptic treatment or physical restraint are used. physical restraint are used. 
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